BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Capricor Therapeutics\, Inc. (CAPR) investor events
X-WR-CALNAME:Capricor Therapeutics\, Inc. (CAPR) investor events
DESCRIPTION:Earnings calls and investor events for Capricor Therapeutics\, 
 Inc. (CAPR)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Capricor Therapeutics\,
  Inc. (CAPR)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:38cf306f-71d7-4acb-9a8b-d670a7e2fcc8@equibles.com
DTSTAMP:20260617T191159Z
DTSTART;VALUE=DATE:20251110
DTEND;VALUE=DATE:20251111
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Earnings Call\, FY2025 Q3
DESCRIPTION:The start time has not been announced.
URL:https://equibles.com/stocks/capr/calls/2025-q3
END:VEVENT
BEGIN:VEVENT
UID:be4366d4-d5ab-446d-a560-149d5318e2fb@equibles.com
DTSTAMP:20260704T195631Z
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260312
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Conference: 2026 Muscular Dystr
 ophy Association (MDA) Clinical and Scientific Conference
DESCRIPTION:2026 Muscular Dystrophy Association (MDA) Clinical and Scientif
 ic Conference\nThe start time has not been announced.\nWebcast: https://ww
 w.capricor.com/investors/news-events/ir-calendar/detail/20260311-2026-musc
 ular-dystrophy-association-mda-clinical-and
URL:https://equibles.com/stocks/capr/events/be4366d4-d5ab-446d-a560-149d531
 8e2fb
END:VEVENT
BEGIN:VEVENT
UID:1b360a98-c62f-4359-989d-770c428fc1ff@equibles.com
DTSTAMP:20260617T191055Z
DTSTART;VALUE=DATE:20260312
DTEND;VALUE=DATE:20260313
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Earnings Call\, FY2025 Q4
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.ca
 pricor.com/investors/news-events/ir-calendar/detail/20260312-capricor-ther
 apeutics-fourth-quarter-2025-financial-results
URL:https://equibles.com/stocks/capr/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:52c4ec04-95cf-45fa-b280-22943acb3404@equibles.com
DTSTAMP:20260617T191139Z
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260513
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://www.ca
 pricor.com/investors/news-events/ir-calendar/detail/20260512-capricor-ther
 apeutics-first-quarter-2026-financial-results
URL:https://equibles.com/stocks/capr/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:56542f2c-52fd-43e1-bd5e-a5fec8ed970e@equibles.com
DTSTAMP:20260704T195631Z
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260516
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Annual General Meeting: America
 n Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
DESCRIPTION:American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Mee
 ting\nThe start time has not been announced.\nWebcast: https://annualmeeti
 ng.asgct.org/register-attend
END:VEVENT
BEGIN:VEVENT
UID:621da52f-d6b1-4b1f-bc21-ee51099a8905@equibles.com
DTSTAMP:20260704T195631Z
DTSTART;VALUE=DATE:20260524
DTEND;VALUE=DATE:20260525
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Conference: CureDuchenne 2026 F
 UTURES National Conference
DESCRIPTION:CureDuchenne 2026 FUTURES National Conference\nThe start time h
 as not been announced.\nWebcast: https://web.cvent.com/event/ee9e7402-2c59
 -420f-9cf9-5731cf20d4d9/summary
END:VEVENT
BEGIN:VEVENT
UID:b669b76e-bdde-40e3-9092-0e2cea6bea4e@equibles.com
DTSTAMP:20260704T195631Z
DTSTART;VALUE=DATE:20260610
DTEND;VALUE=DATE:20260611
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Conference: Goldman Sachs 47th 
 Annual Global Healthcare Conference
DESCRIPTION:Goldman Sachs 47th Annual Global Healthcare Conference\nThe sta
 rt time has not been announced.\nWebcast: https://event.webcasts.com/start
 here.jsp?ei=1766324&tp_key=be420d61d4&tp_special=8
URL:https://equibles.com/stocks/capr/events/b669b76e-bdde-40e3-9092-0e2cea6
 bea4e
END:VEVENT
BEGIN:VEVENT
UID:4de9ca4e-59f1-45e2-9ec3-b3931e100664@equibles.com
DTSTAMP:20260704T195631Z
DTSTART;VALUE=DATE:20260627
DTEND;VALUE=DATE:20260628
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Conference: PPMD's 2026 Annual 
 Conference
DESCRIPTION:PPMD's 2026 Annual Conference\nThe start time has not been anno
 unced.\nWebcast: https://web.cvent.com/event/4c265373-9bde-4c0a-9d7e-92230
 2d52dbd/summary
END:VEVENT
BEGIN:VEVENT
UID:609011ac-4d10-47ca-ad4b-cc2966ffcd6f@equibles.com
DTSTAMP:20260811T044840Z
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260814
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Capricor Therapeutics\, Inc. (CAPR) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://viavid
 .webcasts.com/starthere.jsp?ei=1772191&tp_key=cb3195a60e
URL:https://equibles.com/stocks/capr/calls/2026-q2
END:VEVENT
END:VCALENDAR